Atlas Trials

A Quality of Life Study of Peginterferon-Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C and Persistently Normal Alanine Transaminase (ALT) Levels

Clinical trial NCT02726022 · COMPLETED

Trial details

NCT number
NCT02726022
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatitis C, Chronic
Start date
2007-02-01
Primary completion
2011-07-01
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.